69 related articles for article (PubMed ID: 34933080)
21. Microfluidics-Prepared Ultra-small Biomimetic Nanovesicles for Brain Tumor Targeting.
Wang J; Ma X; Wu Z; Cui B; Zou C; Zhang P; Yao S
Adv Healthc Mater; 2024 Feb; 13(5):e2302302. PubMed ID: 38078359
[TBL] [Abstract][Full Text] [Related]
22. Corrigendum to Journal of Pharmaceutical Sciences Volume 110 (2021) 2946-2954.
Wang H; Chen W; Wu G; Kong J; Yuan S; Chen L
J Pharm Sci; 2024 Jun; 113(6):1690-1692. PubMed ID: 38554930
[No Abstract] [Full Text] [Related]
23. Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands.
Moreira R; Nóbrega C; de Almeida LP; Mendonça L
J Nanobiotechnology; 2024 May; 22(1):260. PubMed ID: 38760847
[TBL] [Abstract][Full Text] [Related]
24. New Transferrin Receptor-Targeted Peptide-Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity.
Yu J; Mao X; Yang X; Zhao G; Li S
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675578
[TBL] [Abstract][Full Text] [Related]
25. Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings.
Begagić E; Pugonja R; Bečulić H; Čeliković A; Tandir Lihić L; Kadić Vukas S; Čejvan L; Skomorac R; Selimović E; Jaganjac B; Juković-Bihorac F; Jusić A; Pojskić M
Brain Sci; 2023 Nov; 13(11):. PubMed ID: 38002561
[TBL] [Abstract][Full Text] [Related]
26. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
Muzyka L; Goff NK; Choudhary N; Koltz MT
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445633
[TBL] [Abstract][Full Text] [Related]
27. Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas.
Hey G; Rao R; Carter A; Reddy A; Valle D; Patel A; Patel D; Lucke-Wold B; Pomeranz Krummel D; Sengupta S
J Pers Med; 2023 May; 13(5):. PubMed ID: 37241023
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Trends in the Research on Transferrin Receptor-Mediated Drug Delivery via a Bibliometric and Thematic Analysis.
Kaur T; Upadhyay J; Pukale S; Mathur A; Ansari MN
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559067
[TBL] [Abstract][Full Text] [Related]
29. Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles.
Thomsen MS; Johnsen KB; Kucharz K; Lauritzen M; Moos T
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297671
[TBL] [Abstract][Full Text] [Related]
30. Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.
Parrasia S; Szabò I; Zoratti M; Biasutto L
Mol Pharm; 2022 Nov; 19(11):3700-3729. PubMed ID: 36174227
[TBL] [Abstract][Full Text] [Related]
31. The pH-Responsive Liposomes-The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells.
Rustad EAL; von Hofsten S; Kumar R; Lænsman EA; Berge G; Škalko-Basnet N
Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745698
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy.
Foglizzo V; Marchiò S
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626078
[TBL] [Abstract][Full Text] [Related]
33. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
34. Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT.
Zong T; Mei L; Gao H; Shi K; Chen J; Wang Y; Zhang Q; Yang Y; He Q
J Pharm Sci; 2014 Dec; 103(12):3891-3901. PubMed ID: 25339554
[TBL] [Abstract][Full Text] [Related]
35. An update on actively targeted liposomes in advanced drug delivery to glioma.
Mojarad-Jabali S; Farshbaf M; Walker PR; Hemmati S; Fatahi Y; Zakeri-Milani P; Sarfraz M; Valizadeh H
Int J Pharm; 2021 Jun; 602():120645. PubMed ID: 33915182
[TBL] [Abstract][Full Text] [Related]
36. Recent Approaches and Success of Liposome-Based Nano Drug Carriers for the Treatment of Brain Tumor.
Shaw TK; Paul P
Curr Drug Deliv; 2022; 19(8):815-829. PubMed ID: 34961462
[TBL] [Abstract][Full Text] [Related]
37. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy.
Mojarad-Jabali S; Farshbaf M; Hemmati S; Sarfraz M; Motasadizadeh H; Shahbazi Mojarrad J; Atyabi F; Zakeri-Milani P; Valizadeh H
Int J Pharm; 2022 Feb; 613():121395. PubMed ID: 34933080
[TBL] [Abstract][Full Text] [Related]
38. Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.
Zhang Y; Zhai M; Chen Z; Han X; Yu F; Li Z; Xie X; Han C; Yu L; Yang Y; Mei X
Drug Deliv; 2017 Nov; 24(1):1045-1055. PubMed ID: 28687044
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
